JYOTHYLAB · Jyothy Labs Ltd · Personal & Household Prods.
JYOTHYLAB · Jyothy Labs Ltd · Personal & Household Prods.
As of 06 Nov close
52-week range
37.9% below 52-week high
52-week range: as of 06 Nov 2026 close.
Price chartDaily closes on the stock page.
Weighted combination of 8 measured readings. Not a probability, a rating or a forecast.
Full signal detail →Fundamentals as of 15 Sep 2026 · the company's own latest record is 53 days old
Revenue (latest Q)
₹773 Cr
Revenue YoY
PAT YoY
-50.8%
Operating margin
Revenue, last 8 quarters
P/E (TTM)
P/B
4.8
P/S (TTM)
2.4
Sector P/E
Not available from data source
Dividend yield
+1.8%
| Company | P/E | P/B | Net margin | ROE | D/E | Div. yield |
|---|---|---|---|---|---|---|
| JYOTHYLAB (this stock) | 24.8 | 4.8 | +9.6% | +17.9% | 0.03 | +1.8% |
| Hindustan Unilever | 47.5 | 10.3 | +22.5% | +30.7% | 0.03 | +2.1% |
| Godrej Consumer Products | 54 | 36.4 | +12.2% | +15.1% | 0.35 | +2.3% |
| Marico | 57.4 | 62.3 | +13.2% | +44.9% | 0.13 | +0.5% |
Promoter
stable
FII
falling 2q
MF
12.03% (-1.12pp)
falling 3q
Insider trades
| Date | Insider | Type | Qty | Value |
|---|---|---|---|---|
| 15 Nov 2025 | M. P. Ramachandran | SELL | 64,11,011 | — |
| 15 Nov 2025 | M. G. Shanthakumari | SELL | 14,36,39,870 | — |
| 15 Nov 2025 | M P Ramachandran Family Trust I | BUY | 64,11,011 | — |
Bulk/block deals
No bulk/block deals in the last 12 months.
News timeline
No related news.
Concalls & investor presentations
AI-generatedKey takeaway: During the Q1 FY27 earnings conference call, management reported that rural demand remained resilient, while urban markets faced challenges due to higher household expenses and cautious consumer sentiment. They noted that commodity inflation impacted margins significantly, particularly in Fabric Care and Home Care segments. Management indicated that while they took price increases, these were insufficient to offset rising raw material costs. They guided toward double-digit revenue growth for FY27, excluding the Pril business, but acknowledged that EBITDA margins would remain under pressure in the first half of the year. The company emphasized a focus on cost optimization and supply chain efficiencies to restore profitability. Management also discussed the performance of various product segments, highlighting strong growth in Fabric Care, while Personal Care faced challenges. They mentioned plans to invest in advertising and brand building to support long-term growth. Overall, the management expressed cautious optimism about future demand and margin recovery.
The management conveyed both challenges and opportunities in the current operating environment.
Sourced from an exchange-filed transcript, dated 14 Aug 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: Jyothy Labs Limited's investor presentation detailed the company's performance for the quarter ended June 30, 2026. The company reported a revenue of ₹773 crores, reflecting a 3% increase from the previous year. However, gross margins decreased to 38.5% from 48% due to inflation in raw materials and packaging costs. Operating EBITDA fell to 8.4%, and profit after tax (PAT) decreased by 50.8% to ₹47.6 crores. The presentation highlighted mixed demand trends, with rural resilience contrasted by subdued urban consumption. Management noted the importance of brand strength and distribution reach as critical growth differentiators. The company outlined its strategy to drive volume-led growth while focusing on operational excellence and supply-chain efficiency. Segment-wise, Fabric Care led with a 52% share, followed by Home Care at 36% and Personal Care at 12%. The presentation also discussed new product developments and marketing initiatives aimed at strengthening brand presence.
The presentation reported both growth in revenue and significant declines in profitability.
Sourced from an exchange-filed presentation, dated 12 Aug 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: Jyothy Labs Limited's investor presentation detailed the company's performance for the quarter ended June 30, 2026. The company reported a revenue of ₹773 crores, reflecting a 3% increase from the previous year. However, gross margins decreased to 38.5% from 48% due to inflation in raw materials and packaging costs. Operating EBITDA fell to 8.4%, and profit after tax (PAT) decreased by 50.8% to ₹47.6 crores. The presentation highlighted mixed demand trends, with rural resilience contrasted by subdued urban consumption. Management noted the importance of brand strength and distribution reach as critical growth differentiators. The company outlined its strategy to drive volume-led growth while focusing on operational excellence and supply-chain efficiency. Segment-wise, Fabric Care showed a growth of 14.1%, while Home Care and Personal Care faced declines. The presentation also discussed brand initiatives and the company's approach to market challenges.
The presentation conveyed both positive growth in revenue and challenges in margins and profitability.
Sourced from an exchange-filed presentation, dated 12 Aug 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: During the conference call held on June 18, 2026, management provided updates regarding the Pril and Fa brands, which Jyothy Labs has managed under license agreements with Henkel for nearly 15 years. Management reported that Henkel decided not to renew these licenses, effective June 1, 2026, leading Jyothy Labs to cease all activities related to these brands. The company has initiated arbitration to assert its contractual rights regarding the exit process and valuation matters. Management acknowledged that the exit would impact revenue and margins in the near term, particularly as Pril has historically been a significant contributor to the Dishwash Liquids segment. Jyothy Labs plans to focus on strengthening its Exo brand and is exploring new product developments to mitigate the revenue loss. The company emphasized its commitment to maintaining operational fundamentals and long-term value creation despite the transition challenges.
Management highlighted both challenges and ongoing strategies for future growth.
Sourced from an exchange-filed transcript, dated 22 Jun 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: Management reported that FY26 was marked by volatility in the FMCG sector, with uneven urban demand and elevated input costs, particularly influenced by geopolitical events in West Asia. Despite these challenges, Jyothy Labs achieved a revenue growth of 3.5% in value and 6% in volume for the year. The Fabric Care segment saw significant growth, particularly in liquid detergents, while the Dishwash segment faced competitive pressures leading to a decline in value despite volume growth. Management noted a mixed demand environment in Q4, with early signs of recovery in urban markets. Input cost inflation, particularly from crude oil, impacted gross margins, which decreased by 400 basis points year-on-year. The company remains debt-free with a strong cash balance and has initiated selective price increases to manage margin pressures. Management expressed cautious optimism for FY27 while acknowledging ongoing uncertainties in the external environment.
Management highlighted both growth achievements and challenges faced in the current market environment.
Sourced from an exchange-filed transcript, dated 07 May 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: The investor presentation from Jyothy Labs Limited detailed the company's performance for the quarter and financial year ended March 31, 2026. Management reported a revenue of Rs 2,944 crores for FY26, reflecting a 3.5% increase year-over-year, with a volume growth of 6%. The presentation highlighted that Fabric Care remained a key growth driver, with liquid detergents experiencing significant growth. Despite a challenging demand environment, management noted a 6% volume growth and a 26% increase in Modern Trade, E-commerce, and Quick Commerce channels. However, margins faced pressure due to rising input costs, with gross margins reported at 47.0%, down from 50.2% the previous year. The company emphasized a focus on growth over margins and indicated that organized channels would continue to be crucial for future growth. The presentation also included an overview of the company's ESG initiatives and future strategies.
The presentation conveyed both growth achievements and challenges related to margin pressures.
Sourced from an exchange-filed presentation, dated 04 May 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: Management reported that Jyothy Labs Limited entered Q3 FY '26 with a favorable macro backdrop, noting signs of revival in the FMCG sector due to easing inflation and improved consumer confidence. The company highlighted a recovery in demand for daily essentials and home care products, particularly in rural markets. Fabric Care achieved a 9.2% value growth driven by volume, while the Personal Care segment returned to profitable growth with nearly 11% value growth. However, the Dishwash category faced challenges with a 1.3% value decline despite 7% volume growth due to competitive pricing pressures. For the nine-month period ending December 2025, revenue grew by 2.2% in value terms, with a noted decline in gross margins attributed to MRP cuts and elevated input costs. Management expressed cautious optimism about sustained recovery in consumption and emphasized ongoing cost discipline and executional agility.
The document presented both positive growth indicators and challenges related to margin pressures and competitive pricing.
Sourced from an exchange-filed transcript, dated 13 Feb 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: Jyothy Labs Limited's investor presentation detailed the company's performance for the quarter and nine months ended December 31, 2025. The presentation reported a revenue of Rs 740 crores for Q3 FY26, reflecting a 5.1% increase, with a volume growth of 7.2%. However, gross margins decreased to 46.5% from 49.8% year-on-year. For the nine-month period, revenue was Rs 2,227 crores, up 2.2%, while profit after tax (PAT) fell to Rs 265.7 crores, down 9.7% from the previous year. Management highlighted resilient rural demand and a recovery in urban consumption, although gross margins faced pressure due to price reductions and inflation. The company aims to drive volume-led growth and focus on premium products to mitigate margin pressures. The presentation also outlined brand performance and initiatives across various categories, emphasizing innovation and market expansion.
The presentation highlighted both growth in revenue and challenges in margins.
Sourced from an exchange-filed presentation, dated 09 Feb 2026. Summary is RedixFi-generated and distinct from investment advice.
AI Summary of Annual Report
AI-generatedJyothy Labs Limited's FY2023-24 annual report highlights strong corporate governance, including a diverse board and ESG integration, with no major financial defaults or regulatory penalties noted. The company initiated insolvency processes against two entities, Abhiraami Chemicals Limited (ACL) and Khadyota Kishan Foundation (KRDC), with ACL's dissolution finalized in May 2024. No material audit issues, liquidity risks, or negative net worth were reported. The report emphasizes adherence to legal and regulatory requirements, with no significant disputes or contingent liabilities beyond routine operations. Financial performance details are not explicitly provided in the supplied evidence.
- Initiated insolvency processes against ACL and KRDC, with ACL's dissolution completed in May 2024.
- No material audit issues, liquidity risks, or negative net worth reported.
- Strong corporate governance with diverse board and ESG integration.
- No regulatory penalties or defaults noted in the report.
Key takeaway: Jyothy Labs Limited demonstrates robust governance and no significant financial or regulatory risks in FY2023-24, with insolvency actions against two entities completed or pending as noted.
The following annual report excerpts provide qualitative strategic context. Do not treat any specific financial figures in these excerpts as authoritative — they may be incorrectly labeled due to PDF table extraction limitations. For precise financial data, refer to the structured fundamentals data above.
Governance disclosures
AI-generatedNeeds attention
Default / Covenant Breach (3 items)
Items of these kinds are disclosed in the filings. This is a count of disclosed items. It is not a finding about the company and its cause has not been independently established.
Default / Covenant Breach
3 occurrencesRecent (last 12 months)
The company received its entitled amount during the liquidation of ACL on September 14, 2023, and the NCLT dissolved ACL on May 9, 2024. The company also initiated insolvency resolution against KRDC, leading to its liquidation, which is pending final hearing.
Earlier (1-3 years ago)
The company filed an application under the Insolvency and Bankruptcy Code, 2016 against Abhiraami Chemicals Limited (ACL) as a financial creditor, and the application was admitted by the National Company Law Tribunal on October 04, 2021.
Abhiraami Chemicals Limited (ACL) underwent corporate insolvency resolution process and subsequent liquidation as per Insolvency and Bankruptcy Code, 2016, with the National Company Law Tribunal (NCLT) approving liquidation and dissolution on May 9, 2024.
Routine disclosures
Internal Control Weakness
1 occurrenceEarlier (1-3 years ago)
The financial statements of a subsidiary with total assets of ` Nil lacs, revenues of ₹382 lacs, and net cash outflows of ₹5 lacs for the year ended 31 March 2025 have not been audited by the auditor or any other auditor.
Contingent Liability
3 occurrencesRecent (last 12 months)
Jyothy Labs Limited has contingent liabilities related to disputed tax matters (sales tax, excise duty, service tax, income tax) under appeal, with pending litigations and proceedings. The company has disclosed these as contingent liabilities in its financial statements.
Earlier (1-3 years ago)
The company has pending legal proceedings that are disclosed as contingent liabilities, though it expects no materially adverse effect on its financial position.
The company has contingent liabilities related to disputed tax matters (sales tax, excise duty, service tax, and income tax) under appeal, where it believes these matters have a strong possibility of being dismissed in its favor, and no provisions have been made.
Related-Party Transaction
1 occurrenceEarlier (1-3 years ago)
The company has entered into related party transactions during the financial year under report, as stated in the statement of related party transactions.
Management & Board Governance
1 occurrenceEarlier (1-3 years ago)
The Chief Financial Officer, Mr. Sanjay Agarwal, resigned on August 21, 2024, and ceased to be a member of the ESG Committee. Mr. Pawan Kumar Agarwal was appointed as the new CFO and ESG Committee member on November 12, 2024.
Promoter Share Pledge
1 occurrenceRecent (last 12 months)
1.31% of promoter holding pledged (quarter 2026-Q3 as of 2026-07-18).